InsiderTrades.com logo

MGRX Insider Trading

Insider Ownership Percentage: 16.00%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $5,091.75

Mangoceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Mangoceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Mangoceuticals Share Price & Price History

Current Price: $3.91
Price Change: ▼ Price Decrease of -0.13 (-3.22%)
As of 03/14/2025 04:59 PM ET

This chart shows the closing price history over time for MGRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Mangoceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/25/2024Alex P HamiltonDirectorSell73$69.75$5,091.75704View SEC Filing Icon  
4/10/2023Jacob D CohenCEOBuy1,222$225.00$274,950.0036,777View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Mangoceuticals (NASDAQ:MGRX)

56.72% of Mangoceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at MGRX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Mangoceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/12/2025Geode Capital Management LLC12,003$29K0.0%-90.9%0.482%Search for SEC Filing on Google Icon
2/4/2025Ackerman Capital Advisors LLC34,500$83K0.0%-96.0%1.386%Search for SEC Filing on Google Icon
10/24/2024Ackerman Capital Advisors LLC873,356$0.21M0.1%N/A3.519%Search for SEC Filing on Google Icon
8/8/2023Colonial River Wealth Management LLC36,100$66K0.0%N/A0.216%Search for SEC Filing on Google Icon
7/28/2023Independent Advisor Alliance26,000$48K0.0%N/A0.162%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Mangoceuticals logo
Mangoceuticals, Inc. develops, markets, and sells various men's wellness products and services through a telemedicine platform in the United States. It offers erectile dysfunction (ED) products under the Mango brand and hair loss products under the Grow brand name. The company markets and sells these branded ED and hair loss products online through its website at MangoRx.com. Mangoceuticals, Inc. has a marketing agreement with Marius Pharmaceuticals, LLC to market and sell KYZATREX, an oral testosterone replacement therapy product under the PRIME program. The company was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. is a subsidiary of Cohen Enterprises, Inc.
Read More on Mangoceuticals

Today's Range

Now: $3.91
Low: $3.87
High: $4.06

50 Day Range

MA: $3.68
Low: $2.55
High: $5.60

52 Week Range

Now: $3.91
Low: $2.07
High: $16.80

Volume

12,065 shs

Average Volume

226,380 shs

Market Capitalization

$9.72 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.51

Who are the company insiders with the largest holdings of Mangoceuticals?

Mangoceuticals' top insider shareholders include:
  1. Jacob D Cohen (CEO)
  2. Alex P Hamilton (Director)
Learn More about top insider investors at Mangoceuticals.

Who are the major institutional investors of Mangoceuticals?

Mangoceuticals' top institutional shareholders include:
  1. Ackerman Capital Advisors LLC — 1.39%
  2. Geode Capital Management LLC — 0.48%
Learn More about top institutional investors of Mangoceuticals stock.

Which major investors are selling Mangoceuticals stock?

In the last quarter, MGRX stock was sold by these institutional investors:
  1. Ackerman Capital Advisors LLC
  2. Geode Capital Management LLC